nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—CHUK—EBV LMP1 signaling—PDLIM7—pharynx cancer	0.0939	0.204	CbGpPWpGaD
Mesalazine—MPO—saliva—pharynx cancer	0.0907	0.168	CbGeAlD
Mesalazine—IKBKB—EBV LMP1 signaling—PDLIM7—pharynx cancer	0.0852	0.185	CbGpPWpGaD
Mesalazine—CHUK—epithelium—pharynx cancer	0.0419	0.0775	CbGeAlD
Mesalazine—CHUK—lymphoid tissue—pharynx cancer	0.0323	0.0597	CbGeAlD
Mesalazine—PPARG—neck—pharynx cancer	0.026	0.0482	CbGeAlD
Mesalazine—CHUK—head—pharynx cancer	0.026	0.0481	CbGeAlD
Mesalazine—IKBKB—lymphoid tissue—pharynx cancer	0.0219	0.0406	CbGeAlD
Mesalazine—MPO—epithelium—pharynx cancer	0.02	0.0369	CbGeAlD
Mesalazine—CHUK—lymph node—pharynx cancer	0.0182	0.0337	CbGeAlD
Mesalazine—ALOX5—lymphoid tissue—pharynx cancer	0.0182	0.0336	CbGeAlD
Mesalazine—PPARG—epithelium—pharynx cancer	0.0177	0.0328	CbGeAlD
Mesalazine—IKBKB—head—pharynx cancer	0.0177	0.0327	CbGeAlD
Mesalazine—PTGS2—mouth—pharynx cancer	0.0156	0.0288	CbGeAlD
Mesalazine—MPO—lymphoid tissue—pharynx cancer	0.0154	0.0284	CbGeAlD
Mesalazine—ALOX5—head—pharynx cancer	0.0146	0.0271	CbGeAlD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH7—pharynx cancer	0.0145	0.0315	CbGpPWpGaD
Mesalazine—MPO—spinal cord—pharynx cancer	0.0139	0.0258	CbGeAlD
Mesalazine—PPARG—lymphoid tissue—pharynx cancer	0.0136	0.0252	CbGeAlD
Mesalazine—PTGS1—Phase 1 - Functionalization of compounds—ADH1B—pharynx cancer	0.0127	0.0276	CbGpPWpGaD
Mesalazine—MPO—head—pharynx cancer	0.0124	0.0229	CbGeAlD
Mesalazine—IKBKB—lymph node—pharynx cancer	0.0124	0.0229	CbGeAlD
Mesalazine—PPARG—head—pharynx cancer	0.011	0.0203	CbGeAlD
Mesalazine—ALOX5—lymph node—pharynx cancer	0.0103	0.019	CbGeAlD
Mesalazine—CHUK—BCR signaling pathway—CD79A—pharynx cancer	0.01	0.0219	CbGpPWpGaD
Mesalazine—PTGS1—epithelium—pharynx cancer	0.00947	0.0175	CbGeAlD
Mesalazine—IKBKB—BCR signaling pathway—CD79A—pharynx cancer	0.00911	0.0198	CbGpPWpGaD
Mesalazine—PTGS2—epithelium—pharynx cancer	0.00905	0.0167	CbGeAlD
Mesalazine—MPO—lymph node—pharynx cancer	0.00868	0.0161	CbGeAlD
Mesalazine—PTGS1—Biological oxidations—CNDP2—pharynx cancer	0.00849	0.0185	CbGpPWpGaD
Mesalazine—PTGS1—trachea—pharynx cancer	0.00838	0.0155	CbGeAlD
Mesalazine—PTGS2—trachea—pharynx cancer	0.00801	0.0148	CbGeAlD
Mesalazine—PPARG—lymph node—pharynx cancer	0.0077	0.0142	CbGeAlD
Mesalazine—PTGS1—Biological oxidations—ADH7—pharynx cancer	0.00768	0.0167	CbGpPWpGaD
Mesalazine—CHUK—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.00747	0.0163	CbGpPWpGaD
Mesalazine—PTGS2—lymphoid tissue—pharynx cancer	0.00697	0.0129	CbGeAlD
Mesalazine—IKBKB—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.00678	0.0147	CbGpPWpGaD
Mesalazine—PTGS1—Biological oxidations—ADH1B—pharynx cancer	0.00673	0.0147	CbGpPWpGaD
Mesalazine—PTGS1—spinal cord—pharynx cancer	0.00661	0.0122	CbGeAlD
Mesalazine—MPO—C-MYB transcription factor network—CCND1—pharynx cancer	0.00635	0.0138	CbGpPWpGaD
Mesalazine—PTGS2—spinal cord—pharynx cancer	0.00632	0.0117	CbGeAlD
Mesalazine—PTGS1—head—pharynx cancer	0.00588	0.0109	CbGeAlD
Mesalazine—PTGS2—head—pharynx cancer	0.00562	0.0104	CbGeAlD
Mesalazine—PPARG—Wnt Signaling Pathway Netpath—CCND1—pharynx cancer	0.00544	0.0118	CbGpPWpGaD
Mesalazine—MPO—Folate Metabolism—TP53—pharynx cancer	0.00507	0.011	CbGpPWpGaD
Mesalazine—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—pharynx cancer	0.00476	0.0104	CbGpPWpGaD
Mesalazine—PPARG—Regulation of retinoblastoma protein—CCND1—pharynx cancer	0.0045	0.00979	CbGpPWpGaD
Mesalazine—CHUK—Validated nuclear estrogen receptor alpha network—CCND1—pharynx cancer	0.00433	0.00942	CbGpPWpGaD
Mesalazine—IKBKB—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—pharynx cancer	0.00431	0.00939	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—CD79A—pharynx cancer	0.00427	0.0093	CbGpPWpGaD
Mesalazine—PTGS1—lymph node—pharynx cancer	0.00412	0.00761	CbGeAlD
Mesalazine—PTGS2—lymph node—pharynx cancer	0.00393	0.00728	CbGeAlD
Mesalazine—IKBKB—B Cell Activation—CD79A—pharynx cancer	0.00388	0.00844	CbGpPWpGaD
Mesalazine—CHUK—Leptin signaling pathway—CCND1—pharynx cancer	0.00381	0.0083	CbGpPWpGaD
Mesalazine—IKBKB—Leptin signaling pathway—CCND1—pharynx cancer	0.00346	0.00752	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—CNDP2—pharynx cancer	0.00335	0.00729	CbGpPWpGaD
Mesalazine—CHUK—AGE/RAGE pathway—EGFR—pharynx cancer	0.00331	0.00721	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—EGFR—pharynx cancer	0.00327	0.00712	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ADH7—pharynx cancer	0.00303	0.00659	CbGpPWpGaD
Mesalazine—IKBKB—AGE/RAGE pathway—EGFR—pharynx cancer	0.003	0.00654	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—EGFR—pharynx cancer	0.00297	0.00646	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—CDH1—pharynx cancer	0.00292	0.00636	CbGpPWpGaD
Mesalazine—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.00275	0.00598	CbGpPWpGaD
Mesalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pharynx cancer	0.00274	0.00596	CbGpPWpGaD
Mesalazine—CHUK—p75(NTR)-mediated signaling—TP53—pharynx cancer	0.00268	0.00584	CbGpPWpGaD
Mesalazine—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—pharynx cancer	0.00268	0.00583	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ADH1B—pharynx cancer	0.00266	0.00578	CbGpPWpGaD
Mesalazine—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pharynx cancer	0.00262	0.0057	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—B4GALT5—pharynx cancer	0.00254	0.00552	CbGpPWpGaD
Mesalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—pharynx cancer	0.00249	0.00542	CbGpPWpGaD
Mesalazine—IKBKB—p75(NTR)-mediated signaling—TP53—pharynx cancer	0.00243	0.0053	CbGpPWpGaD
Mesalazine—CHUK—PI-3K cascade—EGFR—pharynx cancer	0.00241	0.00526	CbGpPWpGaD
Mesalazine—CHUK—PI3K/AKT activation—EGFR—pharynx cancer	0.00236	0.00513	CbGpPWpGaD
Mesalazine—CHUK—GAB1 signalosome—EGFR—pharynx cancer	0.00234	0.00509	CbGpPWpGaD
Mesalazine—CHUK—Apoptosis—TP53—pharynx cancer	0.00229	0.00499	CbGpPWpGaD
Mesalazine—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.00229	0.00497	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—CCND1—pharynx cancer	0.00218	0.00474	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis—TP53—pharynx cancer	0.00208	0.00453	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CNDP2—pharynx cancer	0.00207	0.00451	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—CCND1—pharynx cancer	0.00206	0.00449	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—pharynx cancer	0.00195	0.00425	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ADH7—pharynx cancer	0.00188	0.00408	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00181	0.00393	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.0018	0.00393	CbGpPWpGaD
Mesalazine—CHUK—Disease—B4GALT5—pharynx cancer	0.00176	0.00383	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00173	0.00376	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD79A—pharynx cancer	0.00172	0.00375	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.00171	0.00372	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—EGFR—pharynx cancer	0.0017	0.0037	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ADH1B—pharynx cancer	0.00164	0.00358	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—EGFR—pharynx cancer	0.00162	0.00353	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—EGFR—pharynx cancer	0.00162	0.00352	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—EGFR—pharynx cancer	0.00161	0.0035	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—EGFR—pharynx cancer	0.0016	0.00348	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.00158	0.00343	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CCND1—pharynx cancer	0.00157	0.00342	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—B4GALT5—pharynx cancer	0.00157	0.00342	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD79A—pharynx cancer	0.00156	0.0034	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—EGFR—pharynx cancer	0.0015	0.00328	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—EGFR—pharynx cancer	0.0015	0.00328	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.0015	0.00328	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—EGFR—pharynx cancer	0.00149	0.00325	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00148	0.00322	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—EGFR—pharynx cancer	0.00147	0.0032	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CNDP2—pharynx cancer	0.00145	0.00316	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.00143	0.00312	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.00143	0.00311	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00142	0.0031	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00142	0.00308	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—EGFR—pharynx cancer	0.00139	0.00303	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00136	0.00297	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00133	0.0029	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADH7—pharynx cancer	0.00131	0.00286	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—EGFR—pharynx cancer	0.00126	0.00275	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—EGFR—pharynx cancer	0.00123	0.00268	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—pharynx cancer	0.00122	0.00265	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—pharynx cancer	0.00119	0.0026	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00119	0.00259	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CNDP2—pharynx cancer	0.00115	0.00251	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ADH1B—pharynx cancer	0.00115	0.00251	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—B4GALT5—pharynx cancer	0.0011	0.0024	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00107	0.00233	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD79A—pharynx cancer	0.00105	0.00228	CbGpPWpGaD
Mesalazine—PTGS2—Disease—B4GALT5—pharynx cancer	0.00104	0.00227	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADH7—pharynx cancer	0.00104	0.00227	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—pharynx cancer	0.00104	0.00225	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—EGFR—pharynx cancer	0.00103	0.00223	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDH1—pharynx cancer	0.00096	0.00209	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD79A—pharynx cancer	0.000948	0.00206	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—EGFR—pharynx cancer	0.00093	0.00202	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ADH1B—pharynx cancer	0.000914	0.00199	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—B4GALT5—pharynx cancer	0.000874	0.0019	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDH1—pharynx cancer	0.000871	0.00189	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000839	0.00183	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EGFR—pharynx cancer	0.000705	0.00153	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000704	0.00153	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EGFR—pharynx cancer	0.000585	0.00127	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDH1—pharynx cancer	0.000582	0.00127	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—EGFR—pharynx cancer	0.000561	0.00122	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EGFR—pharynx cancer	0.00053	0.00115	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDH1—pharynx cancer	0.000528	0.00115	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—EGFR—pharynx cancer	0.000509	0.00111	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EGFR—pharynx cancer	0.000341	0.000741	CbGpPWpGaD
Mesalazine—CHUK—Disease—EGFR—pharynx cancer	0.000314	0.000684	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EGFR—pharynx cancer	0.000309	0.000672	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCND1—pharynx cancer	0.000281	0.000611	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCND1—pharynx cancer	0.000254	0.000554	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EGFR—pharynx cancer	0.00022	0.000479	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EGFR—pharynx cancer	0.0002	0.000435	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EGFR—pharynx cancer	0.000186	0.000405	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—pharynx cancer	0.000185	0.000402	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—pharynx cancer	0.000168	0.000365	CbGpPWpGaD
